<DOC>
<DOCNO>
EP-0011032
</DOCNO>
<TEXT>
<DATE>
19800514
</DATE>
<IPC-CLASSIFICATIONS>
A61K-39/29 C07G-7/00 C07K-16/08 C07K-14/005 A61K-39/00 <main>A61K-39/29</main> C07K-14/02 
</IPC-CLASSIFICATIONS>
<TITLE>
method for isolation of hbsag.
</TITLE>
<APPLICANT>
merck & co incus<sep>merck & co. inc.<sep>merck &amp; co., inc.126, east lincoln avenue p.o. box 2000rahway new jersey 07065-0900us<sep>merck & co. inc.<sep>
</APPLICANT>
<INVENTOR>
mcaleer william j<sep>wasmuth edward h<sep>mcaleer, william j.<sep>wasmuth, edward h.<sep>mcaleer, william j.717 marietta driveambler, pennsylvania 19002us<sep>wasmuth, edward h.25 church avenuetelford, pennsylvania 18969us<sep>mcaleer, william j.  <sep>wasmuth, edward h. <sep>mcaleer, william j.717 marietta driveambler, pennsylvania 19002us<sep>wasmuth, edward h.25 church avenuetelford, pennsylvania 18969us<sep>
</INVENTOR>
<ABSTRACT>
high purity hbsag is injected into guinea pigs to stimulate  formation of hbsab-positive serum.  gamma globulins  containing hbsab are separated from the serum and the  globulin fraction containing hbsab is isolated and coupled  to a sepharose gel.  hbsag from hbsag-positive plasma is  adsorbed on the gel by formation of an hbsab-hbsag complex.   hbsag is eluted from the column and dialysed.  
</ABSTRACT>
</TEXT>
</DOC>
